Breast Cancer

Papers
(The H4-Index of Breast Cancer is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Reply to β€œIs venous thromboembolism a time-dependent event in breast cancer patients taking tamoxifen?”144
Assessment of nuclear grade-based recurrence risk classification in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative, node-positive high-risk early breast can55
Incidence of and risk factors for non-hematologic toxicity with combined radiotherapy and CDK4/6 inhibitors in metastatic breast cancer using dose-volume parameters analysis: a multicenter cohort stud45
Copy number alteration is an independent prognostic biomarker in triple-negative breast cancer patients40
Number of lines of previous chemotherapy regimen might affect the oucome of sacituzumab govitecan in metastatic triple-negative breast cancer patients33
Patterns of ipsilateral breast tumor recurrence following partial vs. whole-breast irradiation: a retrospective comparative study of breast-conserving therapy31
Low-carbohydrate diet score and risk of breast cancer: findings from a prospective cohort study28
Prognostic model for pulmonary metastasis in patients with HER2-positive breast cancer: a population-based study26
Changes in re-excision rates after publication of guidelines defining positive margins for breast-conserving surgery: a collaborative study of the Japanese breast cancer society21
Factors associated with post acute care utilization after mastectomy for breast cancer patients20
Immune checkpoint inhibition in breast cancer: targeting PD-1/PD-L1 pathway for therapeutic advances20
Development of a deep learning-based automated diagnostic system (DLADS) for classifying mammographic lesions β€” a first large-scale multi-institutional clinical trial in Japan20
Impact of the COVID-19 pandemic on breast cancer diagnosis and treatment trends in Japan19
Emerging roles of KIR2DL4 in cancer immunotherapy19
The role of C1orf50 in breast cancer progression and prognosis19
Community-based outpatient rehabilitation for the treatment of breast cancer-related upper extremity disability: an evaluation of practice-based evidence19
The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment18
Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within breast cancer subtypes and stages among older women: a SEER-Medicare analysis18
Minimal important differences of EORTC QLQ-C30 and QLQ-BR23 for metastatic breast cancer patients in a Japanese population: results from the RESQ trial18
0.90454196929932